Interestingly, it was also observed that simultaneous elevation of S100B and NSE occurred in both of these groups (i.e., with T2DM and NfT2DM after COVID-19), but it was not observed in the groups of individuals with diabetes before COVID-19. The gene discussed is S100B; the disease is COVID-19.